青光眼快速进展者的短期检测:快速进展评估聚类评价(Fast-PACE)研究
Fast-PACE前瞻性队列研究纳入65例原发性开角型青光眼患者的125只眼,采用6个月内两组各5次每周访视的密集聚类检测,随后每6个月单次访视,平均随访25个月。6个月聚类期检测快速进展的敏感度为93%、特异度为85%,作者认为该方法可用于临床试验和高危者短期评估。
要点
- 6个月聚类检测识别总体随访期快速进展眼的敏感度为93%(CI 66%-100%),特异度为85%(CI 77%-90%)。
- 6个月聚类期检测任何进展的敏感度为71%(CI 53%-85%),特异度为94%(CI 88%-98%)。
- 125只眼中30只(24%,CI 16%-34%)在6个月聚类期按功能、结构或两者出现进展。
核心结论
- Fast-PACE研究的聚类检测可在6个月内检出快速进展的青光眼眼。
- 该方法可用于研究延缓青光眼进展干预措施的临床试验,并可能对高危受试者的短期评估有价值。
研究设计与样本
- 前瞻性队列研究,纳入65例原发性开角型青光眼受试者的125只眼。
- 受试者接受2组各5次每周访视(聚类),两组间隔平均6个月,随后每6个月单次访视,总体平均随访25个月(平均17次检测)。
- 每次访视包括标准自动视野计(SAP)24-2和10-2以及频域OCT(SD-OCT)检测,采用广义估计方程调整双眼间相关性。
主要发现
- 6个月聚类期内,基于SAP 24-2平均偏差(MD)进展19/125只眼(15%,CI 9%-24%),基于SAP 10-2 MD进展14只眼(11%,CI 6%-20%),基于视网膜神经纤维层(RNFL)厚度进展16只眼(13%,CI 8%-21%),按功能、结构或两者进展30/125只眼(24%,CI 16%-34%)。
- 总体随访期35只进展眼中25只在6个月聚类期已进展,敏感度71%(CI 53%-85%);总体随访期90只未进展眼中85只在6个月聚类期未进展,特异度94%(CI 88%-98%)。
- 总体随访期按SAP 24-2、SAP 10-2或SD-OCT判定为快速进展者的14只眼中13只在6个月聚类期被识别为进展,识别快速进展的敏感度93%(CI 66%-100%),特异度85%(CI 77%-90%)。
临床怎么用
- 作者认为,该聚类检测方法可用于研究延缓青光眼进展干预措施的临床试验,并可能对高危受试者的短期评估有价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the performance of an intensive, clustered testing approach in identifying eyes with rapid glaucoma progression over 6 months in the Fast Progression Assessment through Clustered Evaluation (Fast-PACE) Study. DESIGN: Prospective cohort study. PARTICIPANTS: A total of 125 eyes from 65 primary open-angle glaucoma (POAG) subjects. METHODS: Subjects underwent 2 sets of 5 weekly visits (clusters) separated by an average of 6 months and then were followed with single visits every 6 months for an overall mean follow-up of 25 months (mean of 17 tests). Each visit consisted of testing with standard automated perimetry (SAP) 24-2 and 10-2, and spectral-domain OCT (SD-OCT). Progression was assessed using trend analyses of SAP mean deviation (MD) and retinal nerve fiber layer (RNFL) thickness. Generalized estimating equations were applied to adjust for correlations between eyes for confidence interval (CI) estimation and hypothesis testing. MAIN OUTCOME MEASURES: Diagnostic accuracy of the 6-month clustering period to identify progression detected during the overall follow-up. RESULTS: A total of 19 of 125 eyes (15%, CI, 9%-24%) progressed based on SAP 24-2 MD over the 6-month clustering period. A total of 14 eyes (11%, CI, 6%-20%) progressed on SAP 10-2 MD, and 16 eyes (13%, CI, 8%-21%) progressed by RNFL thickness, with 30 of 125 eyes (24%, CI, 16%-34%) progressing by function, structure, or both. Of the 35 eyes progressing during the overall follow-up, 25 had progressed during the 6-month clustering period, for a sensitivity of 71% (CI, 53%-85%). Of the 90 eyes that did not progress during the overall follow-up, 85 also did not progress during the 6-month period, for a specificity of 94% (CI, 88%-98%). Of the 14 eyes considered fast progressors by SAP 24-2, SAP 10-2, or SD-OCT during the overall follow-up, 13 were identified as progressing during the 6-month cluster period, for a sensitivity of 93% (CI, 66%-100%) for identifying fast progression with a specificity of 85% (CI, 77%-90%). CONCLUSIONS: Clustered testing in the Fast-PACE Study detected fast-progressing glaucoma eyes over 6 months. The methodology could be applied in clinical trials investigating interventions to slow glaucoma progression and may be of value for short-term assessment of high-risk subjects. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references in the Footnotes and Disclosures at the end of this article.
引用
- Medeiros FA, Malek DA, Tseng H, et al. Short-term Detection of Fast Progressors in Glaucoma: The Fast Progression Assessment through Clustered Evaluation (Fast-PACE) Study. Ophthalmology. 2023. PMID: 38160883. doi:10.1016/j.ophtha.2023.12.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。